Altered cell viability and proliferation activity of peripheral lymphocytes in patients with Alzheimer's disease

Psychiatry Investigation

Volumn 7, Issue 1, 2010, Pages 68-71

  Yoon, Se Chang ^a   Kwon, Young Ah ^b   Kim, Hyeran ^a   Kim, Seonwoo ^b   Jo, Sangmee Ahn ^c   Kim, Doh Kwan ^a,b  

^a Sungkyunkwan University   (South Korea)

^b Samsung Medical Center   (South Korea)

^c Korea National Institute of Health   (South Korea)

Author keywords

Alzheimer's disease; Biomarker; Cell cycle; Cell death; Peripheral lymphocytes

Indexed keywords

PHYTOHEMAGGLUTININ;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CELL CULTURE; CELL CYCLE REGULATION; CELL PROLIFERATION; CELL STIMULATION; CELL VIABILITY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; NERVE CELL NECROSIS; PERIPHERAL LYMPHOCYTE;

EID: 77950833851     PISSN: 17383684     EISSN: None     Source Type: Journal    
DOI: 10.4306/pi.2010.7.1.68     Document Type: Article

References (13)

1. Cummings JL, Cole O. Alzheimer disease. JAMA 2002; 287: 2335-2338.
2. Cotman CW, Anderson AJ. A potential role for apoptosis in neurodegeneration and Alzheimer's disease. Mol Neurobiol 1995; 10: 19-45.
3. Rissman RA, Poon WW, Blurton-Jones M, Oddo S, Torp R, Vrtek MP, et al. Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology. J Clin Invest 2004; 114: 121-130.
4. Gasparini L, Racchi M, Binetti G, Trabucchi M, Solerte SB, Alkon D, et al. Peripheral markers in testing pathophysiological hypotheses and diagnosing Alzheimer's disease. Faseb J 1998; 12: 17-34.
5. 97 as a biochemical marker of Alzheimer's disease. Neuropsychopharmacology 2001; 25: 84-90.
6. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiat Res 1975; 12: 189-198.
7. Ku HM, Kim JH, Kwon FJ, Kim SH, Lee HS, Ko HJ, et al. A study on the reliability and validity of Seoul-Instrumental Activities of Daily Living (S-IADL). J Korean Neuropsychiatr Assoc 2004; 43: 189-199.
8. Morris JC. The Clinical Dementia Rating (CDR) : current version and scoring rules. Neurology 1993; 43: 2412-2414.
9. Robinson Agramonte M, Dorta-Contreras AJ, Lorigados Pedre L. Immune events in central nervous system of early and late onset Alzheimer's disease patients. Rev Neurol 2001; 32: 901-904.
10. Fassbender K, Walter S, Kühl S, Landmann R, Ishii K, Bertsch T, et al. The LPS receptor (CD 14) links innate immunity with Alzheimer's disease. Faseb J 2004; 18: 203-205.
11. Stieler JT, Lederer C, Brückner MK, Wolf H, Holzer M, Gertz HJ, et al. Impairment of mitogenic activation of peripheral blood lymphocytes in Alzheimer's disease. Neuroreport 2001; 12: 3969-3972.
12. Becker EB, Bonni A. Cell cycle regulation of neuronal apoptosis in development and disease. Prog Neurobiol 2004; 72: 1-25.
13. Nagy Z, Combrinck M, Budge M, McShane R. Cell cycle kinesis in lymphocytes in the diagnosis of Alzheimer's disease. Neurosci Lett 2002; 317: 81-84.